Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.31 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14359784 | 0.78 | ALDH1A1 (0.44) | ALDH1A1LMNAPOLBAPOBEC3AAPOBEC3G | |
| SCHEMBL28712707 | 0.74 | ALDH1A1 (0.30) | ALDH1A1LMNAPOLB | |
| SCHEMBL454987 | 0.71 | ALDH1A1 (0.40) | ALDH1A1LMNAPOLBAPOBEC3AAPOBEC3G | |
| SCHEMBL20610513 | 0.69 | ALDH1A1 (0.37) | ALDH1A1LMNAPOLBL3MBTL1SMN1; SMN2 | |
| SCHEMBL6909801 | 0.69 | L3MBTL1 (0.47) | ALDH1A1LMNAPOLBAPOBEC3AAPOBEC3G | |
| SCHEMBL719071 | 0.66 | ALDH1A1 (0.42) | ALDH1A1LMNAPOLBAPOBEC3AAPOBEC3G | |
| SCHEMBL5864292 | 0.66 | — | — | |
| SCHEMBL6911638 | 0.66 | — | — | |
| SCHEMBL27967575 | 0.66 | ALDH1A1 (0.36) | ALDH1A1LMNAPOLB | |
| SCHEMBL16210192 | 0.64 | APOBEC3A (0.45) | ALDH1A1LMNAPOLBAPOBEC3AAPOBEC3G |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2822682-A1 | MICROCAPSULES AND USES THEREOF | Firmenich SA (CH) | 2015-01-14 | — | — | EP | claimed |
| WO-2013079435-A1 | MICROCAPSULES AND USES THEREOF | FIRMENICH SA (CH) | 2013-06-06 | — | — | WO | claimed |
| CN-113316398-B | Seamless capsule, filter and smoking article comprising same | 三生医药株式会社 | 2024-06-11 | — | — | CN | disclosed |
| CN-118159258-A | Composition containing caryophyllene | 三生医药株式会社 | 2024-06-07 | — | — | CN | disclosed |
| US-20240180219-A1 | SEAMLESS CAPSULE STABLY DISINTEGRABLE EVEN IN HIGH-TEMPERATURE AND HIGH-HUMIDITY ENVIRONMENT, AND METHOD FOR PRODUCING THE SAME | MORISHITA JINTAN CO., LTD. (JP) | 2024-06-06 | — | — | US | disclosed |
| EP-3888475-B1 | SEAMLESS CAPSULE, AND FILTER AND SMOKING DEVICE INCLUDING SAME | SUNSHO PHARMACEUTICAL CO LTD (JP) | 2024-04-10 | — | — | EP | disclosed |
| EP-4316472-A1 | DISINTEGRABLE SEAMLESS CAPSULE THAT IS STABLE EVEN IN HIGH-TEMPERATURE AND HIGH-HUMIDITY ENVIRONMENT, AND METHOD FOR PRODUCING SAID SEAMLESS CAPSULE | Morishita Jintan Co., Ltd. (JP) | 2024-02-07 | — | — | EP | disclosed |
| CN-117120042-A | Seamless capsule capable of stably disintegrating even in high-temperature and high-humidity environment and method for producing same | 森下仁丹株式会社 | 2023-11-24 | — | — | CN | disclosed |
| EP-4175682-A1 | APPARATUS AND COMPOSITIONS FOR IMPROVING SCENT DELIVERY | The Procter & Gamble Company (US) | 2023-05-10 | — | — | EP | disclosed |
| EP-4175680-A1 | APPARATUS AND COMPOSITIONS FOR IMPROVING SCENT DELIVERY | The Procter & Gamble Company (US) | 2023-05-10 | — | — | EP | disclosed |
| WO-2022006197-A1 | APPARATUS AND COMPOSITIONS FOR IMPROVING SCENT DELIVERY | THE PROCTER & GAMBLE COMPANY (US) | 2022-01-06 | — | — | WO | disclosed |
| US-20090270516-A1 | Process for Producing Optically Active Theaspirane | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2009-10-29 | — | — | US | disclosed |
| EP-2020225-A2 | Fragrance composition | Kao Corporation (JP) | 2009-02-04 | — | — | EP | disclosed |
| EP-2010293-A2 | CONTROLLED RELEASE OF ACTIVE COMPOUNDS FROM DYNAMIC MIXTURES | Firmenich S.A. (CH) | 2009-01-07 | — | — | EP | disclosed |
| WO-2008142591-A2 | 3- TO 7-MEMBERED 1,3-DIAZA-4-OXO-HETEROCYCLIC DERIVATIVES CAPABLE OF RELEASING ACTIVE ALDEHYDES OR KETONES | FIRMENICH SA (CH) | 2008-11-27 | — | — | WO | disclosed |
| EP-1863827-A1 | HYDROGELS FOR THE CONTROLLED RELEASE OF BIOACTIVE MATERIALS | FIRMENICH SA (CH) | 2007-12-12 | — | — | EP | disclosed |
| WO-2007085991-A2 | CONTROLLED RELEASE OF ACTIVE COMPOUNDS FROM DYNAMIC MIXTURES | FIRMENICH SA (CH) | 2007-08-02 | — | — | WO | disclosed |
| WO-2006100647-A1 | HYDROGELS FOR THE CONTROLLED RELEASE OF BIOACTIVE MATERIALS | FIRMENICH SA (CH) | 2006-09-28 | — | — | WO | disclosed |
| US-20050245407-A1 | Fragrance composition | KAO CORPORATION (JP) | 2005-11-03 | — | — | US | disclosed |
| EP-1552814-A1 | FRAGRANCE COMPOSITION | Kao Corporation (JP) | 2005-07-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090270516-A1 | Process for Producing Optically Active Theaspirane | DHPS, ALDH7A1, FASN | ALDH1A1 38/4885LMNA 2255/4885POLB 720/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.